MENU
+Compare
ADCT
Stock ticker: NYSE
AS OF
Apr 2, 04:59 PM (EDT)
Price
$1.33
Change
-$0.02 (-1.48%)
Capitalization
131.78M

ADCT ADC Therapeutics SA Forecast, Technical & Fundamental Analysis

ADC Therapeutics SA is a commercial-stage oncology-focused biotechnology company... Show more

ADCT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I.Advisor
a Summary for ADCT with price predictions
Apr 01, 2025

ADCT in upward trend: price may ascend as a result of having broken its lower Bollinger Band on March 21, 2025

ADCT may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options. In of 40 cases where ADCT's price broke its lower Bollinger Band, its price rose further in the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The RSI Indicator entered the oversold zone -- be on the watch for ADCT's price rising or consolidating in the future. That's also the time to consider buying the stock or exploring call options.

The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 6 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where ADCT advanced for three days, in of 251 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 134 cases where ADCT Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on March 20, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on ADCT as a result. In of 88 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

The Moving Average Convergence Divergence Histogram (MACD) for ADCT turned negative on March 21, 2025. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 53 similar instances when the indicator turned negative. In of the 53 cases the stock turned lower in the days that followed. This puts the odds of success at .

ADCT moved below its 50-day moving average on March 20, 2025 date and that indicates a change from an upward trend to a downward trend.

The 10-day moving average for ADCT crossed bearishly below the 50-day moving average on March 28, 2025. This indicates that the trend has shifted lower and could be considered a sell signal. In of 13 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where ADCT declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.000) is normal, around the industry mean (13.458). P/E Ratio (0.000) is within average values for comparable stocks, (64.587). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.867). Dividend Yield (0.000) settles around the average of (0.025) among similar stocks. P/S Ratio (1.824) is also within normal values, averaging (251.391).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating slightly worse than average price growth. ADCT’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. ADCT’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.

View a ticker or compare two or three
ADCT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I. Advisor
published Earnings

ADCT is expected to report earnings to rise 61.32% to -40 cents per share on May 12

ADC Therapeutics SA ADCT Stock Earnings Reports
Q1'25
Est.
$-0.40
Q4'24
Beat
by $0.18
Q3'24
Beat
by $0.10
Q2'24
Beat
by $0.08
Q1'24
Beat
by $0.17
The last earnings report on March 27 showed earnings per share of -25 cents, beating the estimate of -43 cents. With 348.17K shares outstanding, the current market capitalization sits at 131.78M.
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
Route de la Corniche 3B
Phone
+41 216530200
Employees
274
Web
https://www.adctherapeutics.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
WVMIX11.120.03
+0.27%
William Blair Mid Cap Value I
JEVNX8.98N/A
N/A
JHancock Disciplined Value Em Mkts EqNAV
NBMIX43.48N/A
N/A
Neuberger Berman Small Cap Growth Inv
TAISX10.84N/A
N/A
Nuveen Quant Intl Small Cap Eq I
GQEIX22.38N/A
N/A
GQG Partners US Select Quality Eq Instl

ADCT and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, ADCT has been loosely correlated with CLRB. These tickers have moved in lockstep 47% of the time. This A.I.-generated data suggests there is some statistical probability that if ADCT jumps, then CLRB could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ADCT
1D Price
Change %
ADCT100%
-4.26%
CLRB - ADCT
47%
Loosely correlated
-7.39%
ANAB - ADCT
41%
Loosely correlated
-1.02%
PRME - ADCT
39%
Loosely correlated
-10.30%
AURA - ADCT
38%
Loosely correlated
-3.24%
VTYX - ADCT
37%
Loosely correlated
-6.96%
More